|
1
|
Lotfollahzadeh S, Recio-Boiles A and Cagir
B: Colon cancer. StatPearls [Internet] Treasure Island (FL):
StatPearls Publishing; 2023
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yu IS and Cheung WY: Metastatic colorectal
cancer in the era of personalized medicine: A more tailored
approach to systemic therapy. Can J Gastroenterol Hepatol.
2018:94507542018.PubMed/NCBI
|
|
4
|
Das V, Kalita J and Pal M: Predictive and
prognostic biomarkers in colorectal cancer: A systematic review of
recent advances and challenges. Biomed Pharmacother. 87:8–19. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xie YH, Chen YX and Fang JY: Comprehensive
review of targeted therapy for colorectal cancer. Signal Transduct
Target Ther. 5:222020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moghimi-Dehkordi B and Safaee A: An
overview of colorectal cancer survival rates and prognosis in Asia.
World J Gastrointest Oncol. 4:71–75. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dice JF: Peptide sequences that target
cytosolic proteins for lysosomal proteolysis. Trends Biochem Sci.
15:305–309. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Olson TS, Terlecky SR and Dice JF:
Targeting specific proteins for lysosomal proteolysis. Biomed
Biochim Acta. 50:393–397. 1991.PubMed/NCBI
|
|
9
|
Chiang HL, Terlecky SR, Plant CP and Dice
JF: A role for a 70-kilodalton heat shock protein in lysosomal
degradation of intracellular proteins. Science. 246:382–385. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cuervo AM and Dice JF: A receptor for the
selective uptake and degradation of proteins by lysosomes. Science.
273:501–503. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cuervo AM and Dice JF: Unique properties
of lamp2a compared to other lamp2 isoforms. J Cell Sci.
113:4441–4450. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cuervo AM and Dice JF: Regulation of
lamp2a levels in the lysosomal membrane. Traffic. 1:570–583. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bandyopadhyay U, Sridhar S, Kaushik S,
Kiffin R and Cuervo AM: Identification of regulators of
chaperone-mediated autophagy. Mol Cell. 39:535–547. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kaushik S and Cuervo AM: The coming of age
of chaperone-mediated autophagy. Nat Rev Mol Cell Biol. 19:365–381.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang M, Luo S, Chen W, Zhao L and Wang X:
Chaperone-mediated autophagy: A potential target for metabolic
diseases. Curr Med Chem. 30:1887–1899. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peng JQ, Han SM, Chen ZH, Yang J, Pei YQ,
Bao C, Qiao L, Chen WQ and Liu B: Chaperone-mediated autophagy
regulates apoptosis and the proliferation of colon carcinoma cells.
Biochem Biophys Res Commun. 522:348–354. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kon M, Kiffin R, Koga H, Chapochnick J,
Macian F, Varticovski L and Cuervo AM: Chaperone-mediated autophagy
is required for tumor growth. Sci Transl Med. 3:109ra1172011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ding ZB, Fu XT, Shi YH, Zhou J, Peng YF,
Liu WR, Shi GM, Gao Q, Wang XY, Song K, et al: Lamp2a is required
for tumor growth and promotes tumor recurrence of hepatocellular
carcinoma. Int J Oncol. 49:2367–2376. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang T, Ren C, Qiao P, Han X, Wang L, Lv
S, Sun Y, Liu Z, Du Y and Yu Z: PIM2-mediated phosphorylation of
hexokinase 2 Is critical for tumor growth and paclitaxel resistance
in breast cancer. Oncogene. 37:5997–6009. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Han Q, Deng Y, Chen S, Chen R, Yang M,
Zhang Z, Sun X, Wang W, He Y, Wang F, et al: Downregulation of
ATG5-dependent macroautophagy by chaperone-mediated autophagy
promotes breast cancer cell metastasis. Sci Rep. 7:47592017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Saha T: LAMP2A overexpression in breast
tumors promotes cancer cell survival via chaperone-mediated
autophagy. Autophagy. 8:1643–1656. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen R, Li P, Fu Y, Wu Z, Xu L, Wang J,
Chen S, Yang M, Peng B, Yang Y, et al: Chaperone-mediated autophagy
promotes breast cancer angiogenesis via regulation of aerobic
glycolysis. PLoS One. 18:e2815772023.
|
|
23
|
Massey AC, Kaushik S, Sovak G, Kiffin R
and Cuervo AM: Consequences of the selective blockage of
chaperone-mediated autophagy. Proc Natl Acad Sci USA.
103:5805–5810. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
André T, Boni C, Mounedji-Boudiaf L,
Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan
P, Bridgewater J, et al: Oxaliplatin, fluorouracil, and leucovorin
as adjuvant treatment for colon cancer. N Engl J Med.
350:2343–2351. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Majidpoor J and Mortezaee K: Steps in
metastasis: An updated review. Med Oncol. 38:32021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pavlova NN, Zhu J and Thompson CB: The
hallmarks of cancer metabolism: Still emerging. Cell Metab.
34:355–377. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
van der Geest LG, Lam-Boer J, Koopman M,
Verhoef C, Elferink MA and de Wilt JH: Nationwide trends in
incidence, treatment and survival of colorectal cancer patients
with synchronous metastases. Clin Exp Metastasis. 32:457–465. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Desantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Aghili M, Izadi S, Madani H and Mortazavi
H: Clinical and pathological evaluation of patients with early and
late recurrence of colorectal cancer. Asia Pac J Clin Oncol.
6:35–41. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Alfaro Alfaro ÁE, Murillo Castillo B,
Cordero García E, Tascón J and Morales AI: Colon cancer
pharmacogenetics: A narrative review. Pharmacy (Basel). 10:952022.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Siegel RL, Miller KD, Goding Sauer A,
Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA and Jemal
A: Colorectal cancer statistics, 2020. CA Cancer J Clin.
70:145–164. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hubert V, Weiss S, Rees AJ and Kain R:
Modulating chaperone-mediated autophagy and its clinical
applications in cancer. Cells. 11:25622022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Arias E and Cuervo AM: Pros and cons of
chaperone-mediated autophagy in cancer biology. Trends Endocrinol
Metab. 31:53–66. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xuan Y, Zhao S, Xiao X, Xiang L and Zheng
HC: Inhibition of chaperone-mediated autophagy reduces tumor growth
and metastasis and promotes drug sensitivity in colorectal cancer.
Mol Med Rep. 23:3602021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Landry WD and Cotter TG: ROS signalling,
NADPH oxidases and cancer. Biochem Soc Trans. 42:934–938. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ning T, Li J, He Y, Zhang H, Wang X, Deng
T, Liu R, Li H, Bai M, Fan Q, et al: Exosomal miR-208b related with
oxaliplatin resistance promotes Treg expansion in colorectal
cancer. Mol Ther. 29:2723–2736. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Farhadi P, Yarani R, Dokaneheifard S and
Mansouri K: The emerging role of targeting cancer metabolism for
cancer therapy. Tumour Biol. 42:10104283209652842020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Weng ML, Chen WK, Chen XY, Lu H, Sun ZR,
Yu Q, Sun PF, Xu YJ, Zhu MM, Jiang N, et al: Fasting inhibits
aerobic glycolysis and proliferation in colorectal cancer via the
Fdft1-mediated AKT/mTOR/HIF1α pathway suppression. Nat Commun.
11:18692020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu Y, Zhao T, Li Z, Wang L, Yuan S and
Sun L: The role of ASCT2 in cancer: A review. Eur J Pharmacol.
837:81–87. 2018. View Article : Google Scholar : PubMed/NCBI
|
